Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-26-071899

Interim CEO & General Counsel gave up 6,638 shares (to pay taxes)

  • Interim CEO & General Counsel acquired 15,625 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Vogt Frederick G Interim CEO & General Counsel 2026-06-05 Option exercise +15,625 569,130 D
Vogt Frederick G Interim CEO & General Counsel 2026-06-05 Shares withheld for taxes −6,638 $4.23 $28,079 562,492 D
Derivatives
Vogt Frederick G Interim CEO & General Counsel 2026-06-05 Option exercise · Restricted Stock Units −15,625 109,382 D
Loading xslF345X06/tm2617137-4_4seq1.xml…